{
  "url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-6",
  "json_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-6.json",
  "legislation": "uksi/2010/1614",
  "legislation_title": "The General Pharmaceutical Council (Appeals Committee Rules) Order of Council 2010",
  "legislation_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010",
  "path": "schedule/paragraph/6",
  "kind": "paragraph",
  "number": "6",
  "heading": "Notice of Hearing",
  "text": "The Notice of Hearing must—\n(a) state—\n(i) the date, time and venue of the hearing, or\n(ii) when the hearing is to be conducted by teleconference or video link, the date and time of the hearing and instructions on how to access the hearing;\n(b) inform the appellant of the appellant’s right to attend the hearing and to be represented or accompanied at the hearing in accordance with rule 13(2) or (3);\n(c) inform the appellant of the provisions relating to—\n(i) evidence set out in rule 8,\n(ii) procedure at hearings set out in rule 12,\n(iii) witness evidence set out in rule 14;\n(d) require the appellant to inform the secretary, within 14 days beginning with the day on which the Notice is served, whether the appellant intends to—\n(i) attend the hearing,\n(ii) be represented at the hearing, and if so, by whom, and\n(iii) seek to call any witnesses at the hearing, and if so, whom; and\n(e) inform the appellant that, if the appellant fails to attend the hearing, the Committee may proceed with the hearing in the appellant’s absence.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sch. rule 6(a) substituted (6.10.2022) by The General Pharmaceutical Council (Amendment) Rules Order of Council 2022 (S.I. 2022/697), art. 1, Sch. rule 2(4)"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. rule 6 in force at 27.9.2010, see rule 1"
    }
  ],
  "outstanding_effects": [
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2010/1614/schedule/paragraph/6",
    "retrieved_at": "2026-10-29T02:38:45.129905+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}